Navigation Links
Boston Scientific Announces Third Quarter Adjustments
Date:10/8/2008

arnings, cash position, financial position and results of operations. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and, future business decisions made by us and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A -- Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A -- Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file thereafter. We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. This cautionary statement is applicable to all forward-looking statements contained in this document.

CONTACT: Paul Donovan<
'/>"/>

SOURCE Boston Scientific
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. ALS Patients and Researchers Unite in Boston for 4th Annual Leadership Summit
2. U.S. District Court in Delaware Reinstates Damage Awards to Cordis Corporation on Patents Infringed by Medtronic, Inc. and Boston Scientific Corporation
3. Message to Boston Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight
4. Healthcare Product Regulatory Professionals to Convene in Boston for RAPS Annual Conference & Exhibition
5. Navilyst Medical Announces Global Debut Today : Former Boston Scientific Business Units Combine to Lead Fluid Management and Vascular Access Markets
6. Child Care Chain Buyout Cause for Community Protests from Boston to L.A.
7. ASTRO, The Wellness Community - Greater Boston Join to Promote Cancer Survivorship
8. Boston Scientific Welcomes Progress on Pain Care Legislation
9. NIH funds highway pollution and health study in Boston, Somerville
10. 23rd AIDS Walk Boston Draws Five-Year Record-Setting 20,000+ Participants, Doubles Runners to 600 and Raises $1.2 Million
11. Sundays AIDS Walk Boston at the Esplanade Gets Tribute from Cyndi Lauper at True Colors Concert Tour Launch Rehearsal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Sunnyvale, California (PRWEB) September 18, 2014 ... Dr. Ellen Brown to the position of Chief Medical ... as Medical Director for several Pathways programs including Pathways ... for patients in San Mateo and Santa Clara Counties. ... for the medical component of Pathway’s patient care program. ...
(Date:9/18/2014)... of the fight for superiority between mutated genes and ... leukaemia, say researchers from the University of Birmingham and ... Reports , investigated Acute Myeloid Leukaemia to understand why ... mature blood cells. , Stem cells in the bone ... The process resembles a production line with genes acting ...
(Date:9/18/2014)... . In ecology, disease ... pathogen tooth and nail, but rather tolerate it to live (and ... is that the disease only progresses very slowly if at ... , Roland Regoes, a senior scientist at ETH Zurich,s Institute of ... about investigating whether there are infected people who are more tolerant ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 Clinical trial ... data on the Edema clinical trial scenario. This report ... trials on Edema. It includes an overview of the ... site of trial conduction across the globe. The databook ... their phase, trial status, prominence of the sponsors and ...
(Date:9/18/2014)... September 18, 2014 This past August, Narconon ... from Roy at the kissing booth during the West Feliciana Animal ... Shelter. “I have loved animals my whole life and have ... those animals being strays who needed a home. Supporting an ... can’t take them all home!” , The CEO of Narconon Louisiana ...
Breaking Medicine News(10 mins):Health News:Dr. Ellen Brown Promoted to Chief Medical Director at Pathways Home Health & Hospice 2Health News:The war on leukemia: How the battle for cell production could be decisive 2Health News:Withdrawal from the evolutionary race 2Health News:Withdrawal from the evolutionary race 3Health News:Edema Therapeutics Clinical Trials Market 2014 Review Report Available at MarketOptimizer.org 2Health News:Edema Therapeutics Clinical Trials Market 2014 Review Report Available at MarketOptimizer.org 3Health News:Edema Therapeutics Clinical Trials Market 2014 Review Report Available at MarketOptimizer.org 4Health News:Narconon New Life Retreat Supports Local Animal Shelter At Recent Fundraiser 2
... set by CDC need to be lowered, experts say , ... levels well below those considered safe are still at risk ... , Currently, the maximum safe blood level of lead is ... the U.S. Centers for Disease Control and Prevention in 1991. ...
... ... of the advisory board for PerfectServe, a healthcare communications company. , ... Knoxville, TN (PRWeb) Sept. 17, 2009 ... healthcare communications company. The board provides guidance on innovative ways to leverage PerfectServe,s physician-contact ...
... PITTSBURGH, Sept. 17 DynaVox Mayer-Johnson, the world,s ... speech, language and learning disabilities, today announced the company received ... Microsoft Corp. This award recognizes DynaVox Mayer-Johnson for its ... products. , , "We are proud to ...
... LANSING, Mich., Sept. 17 Neogen Corporation (Nasdaq: NEOG ) announces the ... Neogen Corporation 1st Quarter Results Webcast, When: Thursday, September ... How: Live over the Internet -- Simply log on to ... Address above., Contact: Terry Maynard of Neogen Corporation, +1-800-234-5333., , ...
... Chief Operating Officer and Future CEO , , TORONTO, ... MDZ ), a leading provider of products and services ... West, President of MDS Nordion, has been appointed Chief Operating ... Chief Executive Officer of MDS Inc., intends to step down ...
... NEW YORK, Sept. 17 /PRNewswire-FirstCall/ - (OTCBB: GVBP.OB) ... that develops novel therapeutic proteins that disrupt the ... signed a collaboration deal with Beckpharma Ltd. ("Beckpharma") ... treatments. , The two companies are joining forces ...
Cached Medicine News:Health News:Even Small Amounts of Lead Harmful to Kids 2Health News:Even Small Amounts of Lead Harmful to Kids 3Health News:Alan Weinstein Named Chairman of PerfectServe Advisory Board 2Health News:DynaVox Mayer-Johnson Receives Microsoft Award 2Health News:MDS Announces CEO Transition Plan 2Health News:MDS Announces CEO Transition Plan 3Health News:MDS Announces CEO Transition Plan 4Health News:GENova Biotherapeutics secures new cancer drugs targets 2Health News:GENova Biotherapeutics secures new cancer drugs targets 3
(Date:9/18/2014)... September 18, 2014 According ... (Surface & Intravascular Systems- Warming & Cooling), Application ... (Surgeon & Anesthesiologist, Nursing & Paramedical Staff) - ... MarketsandMarkets, this report studies the global Temperature Management Market ... The market is expected to reach $2.5 Billion ...
(Date:9/18/2014)... SAN ANTONIO, Texas , Sept. 18, 2014  Casen ... vessels, skin and muscles to harden.  His case is one ... (GVM) in the world.  The only hospital in ... few in the world, offering treatment with the dual wave-length ... in San Antonio . Using a laser ...
(Date:9/18/2014)... , Sept. 18, 2014 Research ... "China PTCA Balloon Market Investment Report, 2014-2016" ... as a indispensable medical device in percutaneous coronary intervention ... stent, but also as a device for pre-/post-stent dilatations. ... related to that of PCI. As national ...
Breaking Medicine Technology:Temperature Management Market Worth $2.5 Billion by 2019 2Temperature Management Market Worth $2.5 Billion by 2019 3Temperature Management Market Worth $2.5 Billion by 2019 4Methodist Children's Hospital In San Antonio, TX Only Hospital In The U.S. Treating Rare Vascular Condition With Dual Wave-Length Laser 2China PTCA Balloon Market Investment Report, 2014-2016 2China PTCA Balloon Market Investment Report, 2014-2016 3
... Medical Systems, a global developer of high-end ultrasound systems, ... number of clinical applications and ranked first or second ... KLAS  "Ultrasound 2011: Innovation on the Move" report. ... monitoring and reporting the performance of information technology and ...
... Suneva Medical, a privately-held aesthetic medical device ... aesthetics injectable business with approval from Health Canada ... dermal filler for nasolabial folds or smile line ... long-lasting treatment, Bellafill provides physicians the opportunity to ...
Cached Medicine Technology:ZONARE Scores in Clinical Applications, Performance and Customer Support & Service in KLAS 2011 Ultrasound Report 2ZONARE Scores in Clinical Applications, Performance and Customer Support & Service in KLAS 2011 Ultrasound Report 3Suneva Medical Announces Canadian Approval of Bellafill™ 2
... Professional Diagnostics is a leading provider of ... DFA test menu that includes kits for ... well as miscellaneous conjugates and components. Our ... wide assortment of substrates and kit sizes ...
... Medical Professional Diagnostics is a leading provider ... and DFA test menu that includes kits ... as well as miscellaneous conjugates and components. ... a wide assortment of substrates and kit ...
... Professional Diagnostics is a leading provider of ... DFA test menu that includes kits for ... well as miscellaneous conjugates and components. Our ... wide assortment of substrates and kit sizes ...
... a leading provider of immunofluorescence assays, with ... that includes kits for autoimmune diseases, infectious ... conjugates and components. Our Impact IFA Test ... substrates and kit sizes to choose from. ...
Medicine Products: